Company Filing History:
Years Active: 2021-2023
Title: Wei Liu: Innovator in T Lymphocyte Production and Vector Transduction
Introduction
Wei Liu is a prominent inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of immunology, particularly in the production and application of T lymphocytes. With a total of 3 patents, his work has the potential to impact cancer treatment and viral infections.
Latest Patents
Wei Liu's latest patents include innovative methods for generating T cells, specifically cytotoxic T lymphocytes, from peripheral blood mononuclear cells. These methods eliminate the need for a separate step of generating and isolating antigen-presenting cells, streamlining the process with a single round of antigen stimulation. Additionally, he has developed methods to enhance vector transduction efficiency into T lymphocytes, which is crucial for improving the effectiveness of gene therapy.
Career Highlights
Wei Liu is currently associated with Celgene Corporation, where he continues to advance research in T cell therapies. His work is instrumental in developing new approaches to treat various diseases, including cancer and viral infections.
Collaborations
Some of his notable coworkers include Bitao Liang and Xiaohua Lu, who collaborate with him on various research projects.
Conclusion
Wei Liu's innovative work in T lymphocyte production and vector transduction represents a significant advancement in medical research. His contributions are paving the way for new therapeutic strategies in the treatment of serious health conditions.